These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 12730807

  • 1. Modulation of matrix gelatinases and metalloproteinase-activating process in acute kidney rejection.
    Laplante A, Liu D, Demeule M, Annabi B, Murphy GF, Daloze P, Chen H, Béliveau R.
    Transpl Int; 2003 Apr; 16(4):262-9. PubMed ID: 12730807
    [Abstract] [Full Text] [Related]

  • 2. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
    Zhang X, Sakamoto T, Hata Y, Kubota T, Hisatomi T, Murata T, Ishibashi T, Inomata H.
    Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
    [Abstract] [Full Text] [Related]

  • 3. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
    Worley JR, Thompkins PB, Lee MH, Hutton M, Soloway P, Edwards DR, Murphy G, Knäuper V.
    Biochem J; 2003 Jun 15; 372(Pt 3):799-809. PubMed ID: 12630911
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of MMP-2/MMP-9 and potential benefit of an MMP inhibitor in experimental acute kidney allograft rejection.
    Ermolli M, Schumacher M, Lods N, Hammoud M, Marti HP.
    Transpl Immunol; 2003 Jun 15; 11(2):137-45. PubMed ID: 12799196
    [Abstract] [Full Text] [Related]

  • 5. Plasmin activates pro-matrix metalloproteinase-2 with a membrane-type 1 matrix metalloproteinase-dependent mechanism.
    Monea S, Lehti K, Keski-Oja J, Mignatti P.
    J Cell Physiol; 2002 Aug 15; 192(2):160-70. PubMed ID: 12115722
    [Abstract] [Full Text] [Related]

  • 6. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes.
    Baumann P, Zigrino P, Mauch C, Breitkreutz D, Nischt R.
    Br J Cancer; 2000 Nov 15; 83(10):1387-93. PubMed ID: 11044366
    [Abstract] [Full Text] [Related]

  • 7. Increased matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase activity and expression in heterotopically transplanted murine tracheas.
    Inaki N, Tsunezuka Y, Kawakami K, Sato H, Takino T, Oda M, Watanabe G.
    J Heart Lung Transplant; 2004 Feb 15; 23(2):218-27. PubMed ID: 14761770
    [Abstract] [Full Text] [Related]

  • 8. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients.
    Ergul A, Portik-Dobos V, Hutchinson J, Franco J, Anstadt MP.
    Am J Hypertens; 2004 Sep 15; 17(9):775-82. PubMed ID: 15363819
    [Abstract] [Full Text] [Related]

  • 9. Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis.
    Oggionni T, Morbini P, Inghilleri S, Palladini G, Tozzi R, Vitulo P, Fenoglio C, Perlini S, Pozzi E.
    Eur J Histochem; 2006 Sep 15; 50(4):317-25. PubMed ID: 17213041
    [Abstract] [Full Text] [Related]

  • 10. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ, Wang Y, Li Q, Tian YJ, Liu MH, Yu YH.
    Chin Med J (Engl); 2006 May 20; 119(10):814-21. PubMed ID: 16732983
    [Abstract] [Full Text] [Related]

  • 11. Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis.
    Papakonstantinou E, Dionyssopoulos A, Aletras AJ, Pesintzaki C, Minas A, Karakiulakis G.
    J Am Acad Dermatol; 2004 Oct 20; 51(4):526-33. PubMed ID: 15389186
    [Abstract] [Full Text] [Related]

  • 12. Aberrant tubulointerstitial immunoexpression of matrix metalloproteinases MMP-2, MMP-9 and tissue inhibitor of matrix proteinase-2 (TIMP-2) in acute cellular rejection of human renal allograft.
    Wagrowska-Danilewicz M, Danilewicz M.
    Pol J Pathol; 2008 Oct 20; 59(4):189-94. PubMed ID: 19391484
    [Abstract] [Full Text] [Related]

  • 13. Fibrosis and matrix metalloproteinases in rat renal allografts.
    Inkinen KA, Soots AP, Krogerus LA, Lautenschlager IT, Ahonen JP.
    Transpl Int; 2005 May 20; 18(5):506-12. PubMed ID: 15819797
    [Abstract] [Full Text] [Related]

  • 14. Ischemia-reperfusion injury stimulates gelatinase expression and activity in kidney glomeruli.
    Caron A, Desrosiers RR, Langlois S, Béliveau R.
    Can J Physiol Pharmacol; 2005 Mar 20; 83(3):287-300. PubMed ID: 15870843
    [Abstract] [Full Text] [Related]

  • 15. PAF-induced furin and MT1-MMP expression is independent of MMP-2 activation in corneal myofibroblasts.
    Ottino P, He J, Axelrad TW, Bazan HE.
    Invest Ophthalmol Vis Sci; 2005 Feb 20; 46(2):487-96. PubMed ID: 15671273
    [Abstract] [Full Text] [Related]

  • 16. Synthetic gelatinases inhibitor attenuates electromagnetic pulse-induced blood-brain barrier disruption by inhibiting gelatinases-mediated ZO-1 degradation in rats.
    Qiu LB, Zhou Y, Wang Q, Yang LL, Liu HQ, Xu SL, Qi YH, Ding GR, Guo GZ.
    Toxicology; 2011 Jul 11; 285(1-2):31-8. PubMed ID: 21501651
    [Abstract] [Full Text] [Related]

  • 17. Basement membrane remodeling in skeletal muscles of patients with limb ischemia involves regulation of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases.
    Baum O, Ganster M, Baumgartner I, Nieselt K, Djonov V.
    J Vasc Res; 2007 Jul 11; 44(3):202-13. PubMed ID: 17337906
    [Abstract] [Full Text] [Related]

  • 18. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ, Chen XM, Cui SW, Cai GY, Shi SZ, Xie YS, Lu Y, Peng LX.
    Zhonghua Yi Xue Za Zhi; 2004 Jun 02; 84(11):937-42. PubMed ID: 15329283
    [Abstract] [Full Text] [Related]

  • 19. Membrane type 1-matrix metalloproteinase (MMP)-associated MMP-2 activation increases in the rat ovary in response to an ovulatory dose of human chorionic gonadotropin.
    Jo M, Thomas LE, Wheeler SE, Curry TE.
    Biol Reprod; 2004 Apr 02; 70(4):1024-32. PubMed ID: 14668206
    [Abstract] [Full Text] [Related]

  • 20. The expression of human corneal MMP-2, MMP-9, proMMP-13 and TIMP-1 in bullous keratopathy and keratoconus.
    Predović J, Balog T, Marotti T, Gabrić N, Bohac M, Romac I, Dekaris I.
    Coll Antropol; 2008 Oct 02; 32 Suppl 2():15-9. PubMed ID: 19138000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.